Sign in
4

Changes in Ownership

Ovid Therapeutics Inc. Filed Acc 0001395064-22-000121

10% owner disposed of 5,750,000 shares (other)

  • 10% owner acquired 5,750,000 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
TAKEDA PHARMACEUTICAL CO LTD 10% owner 2022-07-01 Other disposition −5,750,000 0 I
TAKEDA PHARMACEUTICAL CO LTD 10% owner 2022-07-01 Other acquisition +5,750,000 5,750,000 I
Derivatives
TAKEDA PHARMACEUTICAL CO LTD 10% owner 2022-07-01 Other disposition · Series A Convertible Preferred Stock −1,250 0 I
TAKEDA PHARMACEUTICAL CO LTD 10% owner 2022-07-01 Other acquisition · Series A Convertible Preferred Stock +1,250 1,250 I
Loading xslF345X03/wf-form4_165710328185839.xml…